Aims of this Policy
This policy aims to provide guidance on the precautions which must be taken during clinical procedures and surgery on patients known, suspected or at risk of CJD/TSE, to prevent transmission to others. It also details how instruments and other equipment should be quarantined, decontaminated and/or disposed of.
To ensure the correct procedures are adhered to prevent any onward transmission.
Patient Risk Groups
Patients may be grouped according to whether they have known or suspected CJD/TSE, or are potentially at risk of developing one of these diseases, i.e. who are asymptomatic, but have a clinical or family history which places them in a risk group. The requirements detailed in this policy apply only to patients who fall into one of these groups.
|Compiled by:||The Infection Control Team|
|Ratified by:||Clinical Governance Committee|
|Date Ratified:||August 2017|
|Date Issued:||August 2019|
|Review Date:||March 2020|
|Target Audience:||All Trust staff|
|Contact name:||The Infection Control Team|
- Policy for infection control of CJD and other transmissible spongiform encephalopathies (TSE).